Table 2.
Alteration of tumour-infiltrating CD68+ and CD163+ macrophages in the breast tumours in women with LLABCs undergoing NAC.
| Macrophages | Groups | Post-NAC | p value(3) (pre- versus post-NAC) | ||
|---|---|---|---|---|---|
| Low infiltration (n) | High infiltration (n) | ||||
| CD68+ (n = 16) | Pre-NAC | Low infiltration (n) | 10 | 1 | 0.375 |
| High infiltration (n) | 4 | 1 | |||
|
| |||||
| CD163+ (n = 16) | Pre-NAC | Low infiltration (n) | 4 | 2 | 0.289 |
| High infiltration (n) | 6 | 4 | |||
LLABCs: large and locally advanced breast cancers; NAC: neoadjuvant chemotherapy; (3)related sample McNemar test.